Gen Z wants to quit vaping. Can a new wave of trendy products help?
A rush of Instagram-approved products have flooded the NRT market over the last few years. They have a new audience in mind: ...
FiercePharma4d
Pfizer doubles down with its 2nd FDA hemophilia approval in 6 months
Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...
Medscape4d
FDA Approves Pfizer's Hympavzi for Hemophilia A, B
The monoclonal antibody is the first non-factor, once-weekly treatment approved in the United States for hemophilia B.
FDA approves first once-weekly drug treatment regimen for hemophilia
Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first ...
2 Incredibly Cheap Big Pharma Stocks to Buy Now
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment
The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for ...
The American Journal of Managed Care1d
Navigating the Complexities of Cancer Care: Cannabis and Cost Considerations
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
MedPage Today5d
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors
Opens in a new tab or window The FDA approved marstacimab ... It is the first anti-TFPI approved in the U.S. for the treatment of hemophilia A or B. "Today's approval of Hympavzi provides patients ...
R Street Institute6d
R Street Testimony in Opposition of the Belchertown Board of Health Regulations Restricting the Sale of Reduced Risk Nicotine Products
Jeffrey S. Smith, Senior Fellow, Integrated Harm Reduction, R Street Institute R Street Testimony in Opposition of the Belchertown Board of Health Regulations Restricting the Sale of Reduced Risk ...